A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ViiV Healthcare
With
Pfizer
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects who complete the A4001050 study and are continuing to derive benefit from Maraviroc.
Subjects who are willing and able to comply with scheduled visits, treatment plan and other study procedures.
You may not be if
Subjects who discontinued in A4001050 study.
Unable to provide consent.
Clareo Health | A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India
